English
简体中文
Total: £ 56.28
2026-04-08 | Pages: 116 | Tables: 115
The global Plant-Based Multivitamins Gummies market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econom...
2026-04-08 | Pages: 125 | Tables: 121
The global Calcium Supplements for Middle-Aged and Elderly People market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty i...
2026-04-08 | Pages: 111 | Tables: 120
The global Calcium Supplement Products for Middle-Aged and Elderly People market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Calcium Supplement Produ...
2026-04-08 | Pages: 113 | Tables: 110
The global Famotidine Sodium Chloride Injections market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global ec...
2026-04-08 | Pages: 114 | Tables: 115
The global FPR1 Inhibitor market was valued at US$ 44.47 million in 2025 and is anticipated to reach US$ 55.6 million by 2032, at a CAGR of 3.3% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic l...
2026-04-08 | Pages: 112 | Tables: 116
The global Dihydroquercetin market was valued at US$ 34.08 million in 2025 and is anticipated to reach US$ 50.29 million by 2032, at a CAGR of 5.8% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-04-08 | Pages: 112 | Tables: 119
The global Critical Limb Ischemia Treatment market was valued at US$ 2075 million in 2025 and is anticipated to reach US$ 3484 million by 2032, at a CAGR of 7.8% from 2026 to 2032.Critical limb ischemia (CLI) is a severe blockage in the arteries of t...
2026-04-08 | Pages: 123 | Tables: 124
The global Azelastine market was valued at US$ 464 million in 2025 and is anticipated to reach US$ 557 million by 2032, at a CAGR of 2.7% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscap...
2026-04-08 | Pages: 115 | Tables: 113
The global Anti-allergic Drugs market was valued at US$ 47760 million in 2025 and is anticipated to reach US$ 75120 million by 2032, at a CAGR of 6.8% from 2026 to 2032.Anti-allergic drugs are medications used to treat and prevent allergic reactions ...
2026-04-08 | Pages: 126 | Tables: 133
The global Women's Health market was valued at US$ 36700 million in 2025 and is anticipated to reach US$ 47790 million by 2032, at a CAGR of 3.9% from 2026 to 2032.Women's health refers to the branch of healthcare that focuses on the unique medical n...
2026-04-08 | Pages: 123 | Tables: 139
The global Bone and Joint Health Supplements market was valued at US$ 3746 million in 2025 and is anticipated to reach US$ 4976 million by 2032, at a CAGR of 4.2% from 2026 to 2032.Bone and Joint Health Supplement is a manufactured product intended t...
2026-04-08 | Pages: 149 | Tables: 155
The global Pharmaceutical Aseptic Filling Services market was valued at US$ 3500 million in 2025 and is anticipated to reach US$ 4649 million by 2032, at a CAGR of 4.2% from 2026 to 2032.In pharmaceutical manufacturing, fill-finish operations are cri...
2026-04-08 | Pages: 116 | Tables: 108
The global Hyperkalemia Treatment market was valued at US$ 935 million in 2025 and is anticipated to reach US$ 2591 million by 2032, at a CAGR of 15.9% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global eco...
2026-04-08 | Pages: 108 | Tables: 117
The global Creatine market was valued at US$ 452 million in 2025 and is anticipated to reach US$ 590 million by 2032, at a CAGR of 3.9% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape....
2026-04-08 | Pages: 117 | Tables: 119
The global Alpha 1 Antitrypsin Deficiency Treatment market was valued at US$ 2387 million in 2025 and is anticipated to reach US$ 4327 million by 2032, at a CAGR of 9.0% from 2026 to 2032.Alpha-1 antitrypsin deficiency (A1AD) is a hereditary disorder...
